Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Biogen Inc. is a global biopharmaceutical company specializing in discovering, developing, and delivering therapies for serious neurological, immunological, and rare diseases. Its portfolio includes treatments for multiple sclerosis, spinal muscular atrophy, Alzheimer's disease, amyotrophic lateral sclerosis, and Friedreich’s ataxia. Biogen also commercializes biosimilars and collaborates with partners to advance innovative medicines, leveraging extensive R&D, patent protection, and global marketing to serve patients and healthcare providers worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.